Fin Cascade
Get Android appGet iOS app

Prices as of 9 Oct 2026 close · Not investment advice

Astec LifeSciences Limited

NSE: ASTECPesticides & AgrochemicalsShort-term ASM stage 1

Share price

₹729.30

+2.04% close of 9 Oct 2026

Market cap ₹1,604 CrP/E —

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 9 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

26

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹1,604 Cr

P/E ratio

—

P/B ratio

4.2

ROCE

-5.4%

ROE

-25.3%

Dividend yield

0.0%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 9 Oct 2026 close52-week high ₹918.7552-week low ₹521.85

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 9.3% over the past year, and 11.1% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 20.8% to -0.2% over the last four years.

Whether it grew faster than its sector

It grew 11.1% a year against a sector median of 10.2% — 0.9 percentage points faster.

Room to re-rate, or risk of de-rating

It has no earnings, so there is no price-to-earnings to compare.

Whether growth justifies the valuation

It has no earnings to weigh the price against.

Profit growthPrice per ₹1 profitPer 1% growth
Astec LifeSciences Limited — this one———
UPL Limited-21%/yr20.6×—
PI Industries Limited-1%/yr29.2×—
Sumitomo Chemical India Limited2%/yr35.9×₹17.9
Bayer Cropscience Limited1%/yr20.8×₹20.8
Sharda Cropchem Limited26%/yr10.4×₹0.40

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Pesticides & Agrochemicals), it ranks 23 of 23 on returns, 11 of 23 on growth, 23 of 23 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

It is losing money on the capital in the business, so there is no advantage to measure.

Whether its growth pays for itself

No — Over the last five years it made ₹20 crore of cash from the business but spent ₹377 crore on plant and equipment, ₹357 crore more than it made; the gap was from lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 359 arrived as cash — well above the profit; depreciation and interest are the reason, not a windfall. Its cash comes back faster than it used to: it went from being waiting 12 days for its cash to paid 56 days before it paid its own suppliers.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

5 of 8 checks clear · 63%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 31 Jul 2026 · Consolidated

Revenue

₹84 Cr

Revenue vs last year

-8.3%

Revenue vs last quarter

-47.3%

Net profit

-₹19 Cr

Net margin

-22.4%

EPS

₹-8.40

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹1,604 Cr
Prev close
₹729.30
52w High
₹942
52w Low
₹513
Enterprise value
₹2,041 Cr
Beta
0.7
Price CAGR 1y
-6.0%
Price CAGR 3y
-18.0%
Price CAGR 5y
-10.0%
Price CAGR 10y
5.0%

Ratios

Return on assets
-8.6%
PEG ratio
—
P/E ratio
—
P/B ratio
4.2
EV / EBITDA
408.3
Industry P/E
20.1
ROCE
-5.4%
ROCE 5y average
1.6%
ROE
-25.3%
Debt / Equity
1.2
Interest coverage
-1.3
Dividend yield
0.0%
ROE 3y average
-26.0%
ROE last year
-25.0%

Annual P&L

Annual revenue
₹448 Cr
Annual profit
-₹81 Cr
Operating margin
-1.0%
Net profit margin
-18.1%
EBITDA margin
-0.9%
Sales growth 3y
-10.6%
Sales growth 5y
-4.2%
Profit growth 3y
—
Profit growth 5y
—
EPS
₹-36.3
Sales growth TTM
9.0%
Profit growth TTM
50.0%
Dividend payout
0.0%

Quarter P&L

Sales latest quarter
₹84 Cr
Profit latest quarter
-₹19 Cr
YoY quarterly sales growth
-8.3%
YoY quarterly profit growth
—
OPM latest quarter
-0.8%

Balance Sheet

Book Value
₹177
Face Value
₹10.0
Total debt
₹449 Cr
Total cash
₹12 Cr
Borrowings
₹449 Cr
Reserves / Equity
16.7

Cash Flow

Operating cash flow
-₹81 Cr
Free cash flow
-₹86 Cr
FCF yield
-7.5%
Net cash flow
₹9 Cr

Shareholding

Promoter holding
72.0%
FII holding
0.0%
DII holding
3.3%
Public holding
24.7%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
UPL495.0021.241,9131.21-73.092.610,181.010.510.1
P I Industries2,210.0031.033,5300.68244.2-39.01,702.3-10.415.0
Sumitomo Chemi.421.9536.821,0390.31216.59.31,054.10.623.5
Bayer Crop Sci.3,491.5021.415,6864.30321.615.41,835.0-4.229.1
Sharda Cropchem742.0510.76,7032.0288.0-38.31,073.89.030.3
Dhanuka Agritech891.8014.93,9850.2236.3-34.6461.9-12.623.8
Rallis India200.0317.03,8861.50125.030.01,022.06.814.1
Astec Lifescienc748.201,6670.00-18.743.383.6-8.3-5.4
Median316.2021.11,6530.1724.616.8383.7-2.315.4

Competes with: Bayer Cropscience Limited, Dhanuka Agritech Limited, NACL Industries Limited, PI Industries Limited, Rallis India Limited, Sharda Cropchem Limited, Sumitomo Chemical India Limited, UPL Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales14311151154699994120917412515984
Expenses140114691411161181001141028012114984
Material Cost855958827176
Change in Inventories-124.48-171.2639-34
Purchases of Stock-in-Trade000000
Employee Cost141516161616
Other Expenses262324222326
Operating Profit3-3-1813-46-20-66-11-749-1
OPM %2.19-3.10-368.26-67-20-6.124.63-12-9.073.195.77-0.80
Other Income2112122111-131
Exceptional items (within Other Income)000-2.0900
Interest6667791010118788
Depreciation999991111121110111211
Profit before tax-11-18-32-1-62-39-25-16-33-24-16-8-19
Tax %-26-24-244-360613000-2-0
Net Profit-8-13-24-1-40-39-40-16-33-24-16-8-19
EPS in Rs-3.66-6-11-0.43-18-17-18-7.18-15-11-7.05-3.48-8.40
Diluted EPS in Rs-8.20-17-11-7.04-3.48-8.40

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales267233299368431523555677628458381448441
Expenses213201236299354437443522551464448453435
Material Cost249270
Change in Inventories4828
Purchases of Stock-in-Trade00
Employee Cost6163
Other Expenses8991
Operating Profit54326369768511215477-6-66-46
OPM %201421191816202312-1.30-17-11.30
Other Income-164-8121112810136633
Exceptional items (within Other Income)0-2.09
Interest131312111213592125373531
Depreciation13101415192326343436444544
Profit before tax1312295656618912135-62-141-81-67
Tax %-175933373623272627-24-4-0
Net Profit15519353648659026-47-135-81-67
EPS in Rs6.662.248.57161621294011-21-60-36-30
Diluted EPS in Rs-69-38
Dividend Payout %160158865312000

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
7%
5 years
-4%
3 years
-11%
TTM
9%

Compounded profit growth

10 years
—
5 years
—
3 years
—
TTM
50%

Stock price CAGR

10 years
5%
5 years
-10%
3 years
-18%
1 year
-6%

Return on equity

10 years
2%
5 years
-8%
3 years
-26%
Last year
-25%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital191920202020202020202022
Reserves11699119150183227290377400350215368
Borrowings9312712712517699187279341494555449
Other Liabilities13385691198322618122121911292102
Minority Interest0.270.31
Total Liabilities362330334413461572678897979975881942
Fixed Assets13395103115167194213340318386499459
CWIP12208421924116231271652120
Investments000000000000
Other Assets216215223256275354349534534424361463
Total Assets362330334413461572678897979975881942

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity7-13196515168-8247510-8-81
Cash from Investing Activity-19-17-18-49-52-74-73-104-113-135-15-4
Cash from Financing Activity1231-1-1837-958180381252494
Net Cash Flow-021-3-0000-0009
Free Cash Flow-13-39-115-37123-111-80-42-125-24-86

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days14212613512210311212314890135141202
Inventory Days147177133122121131113176268224196169
Days Payable17916911615583218137179161102100107
Cash Conversion Cycle1091341528914225100145197256237263
Working Capital Days19-281-8-28412-17-1-26-56
ROCE %20122022202022228-4-13-5

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters676767676767717172727272
FIIs1.331.281.251.030.531.200.250.0200.040.030.01
DIIs109.747.883.374.505.404.344.264.013.173.333.33
Public222224292827252524252525
No. of Shareholders18,72219,24419,84819,95519,72719,05718,68918,54918,27622,29321,04119,889

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -4.5% (₹763.60 → ₹729.30)Brick size ₹45.87 (fixed)Bricks 25
₹600₹800₹900₹729Nov '25Mar '26Jul '26
Price moved up one brickPrice moved down one brickLast close ₹729.30 on 9 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

437inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

95,14,769inr

2026-03-31

News

News and filings about Astec LifeSciences Limited. Open one to see why it matters.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • 1,2,4-Triazole / 1H-1,2,4-triazole sodium
  • Allyl chloride
  • Chloromethyl trimethylsilane
  • Dimethylacetamide (DMAC)
  • Dimethylformamide (DMF)
  • Ethyl chloroformate
  • Meta-dichlorobenzene
  • N-methyl pyrrolidone (NMP)
  • Tetrahydrofuran (THF)

Buys from

Sells to

  • Godrej Agrovet Limited · Agrochemical active ingredients (technicals) & formulations — parent Godrej Agrovet is a k…

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Pesticides & Agrochemicals
Classification
Chemicals › Pesticides & Agrochemicals
ISIN
INE563J01010

Business segments

  • Outside India · 68%
  • Within India · 32%

Plants

  • Adi Godrej Center for Chemical R&D
  • Herbicide Manufacturing Plant
  • Mahad Manufacturing Plants

News impact

Big market events that reach Astec LifeSciences Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

21 Jul 2023unspecified₹1.5
19 Jul 2022unspecified₹1.5
22 Jul 2021unspecified₹1.5
16 Jul 2020unspecified₹1.5
18 Jul 2019unspecified₹1.5
19 Jul 2018unspecified₹1.5
17 Jul 2017unspecified₹1.5
15 Sep 2015unspecified₹1.25

Splits, bonuses & buybacks

  • daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016

Bulk & block deals

DateWhoBought / soldSharesPrice
9 Sep 2026MICROCURVES TRADING PRIVATE LIMITEDBUY2,55,931₹752.60
9 Sep 2026MICROCURVES TRADING PRIVATE LIMITEDSELL2,55,931₹753.10
9 Sep 2026JUNOMONETA FINSOL PRIVATE LIMITEDSELL1,96,601₹754.71
9 Sep 2026JUNOMONETA FINSOL PRIVATE LIMITEDBUY1,93,946₹754.50
9 Sep 2026ALPHAGREP SECURITIES PRIVATE LIMITEDSELL1,90,586₹749.68
9 Sep 2026ALPHAGREP SECURITIES PRIVATE LIMITEDBUY1,90,586₹749.27
9 Sep 2026QE SECURITIES LLPSELL1,80,734₹750.44
9 Sep 2026QE SECURITIES LLPBUY1,80,108₹754.57
9 Sep 2026NK SECURITIES RESEARCH PRIVATE LIMITEDSELL1,72,956₹752.70
9 Sep 2026NK SECURITIES RESEARCH PRIVATE LIMITEDBUY1,72,956₹752.39

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.